536
Participants
Start Date
March 22, 2018
Primary Completion Date
March 18, 2020
Study Completion Date
March 18, 2020
LY2963016
Administered SC
Lantus®
Administered SC
Peking Union Medical College Hospital, Beijing
Shengjing Hospital of China Medical University, Shenyang
Dalian Med. Univ. No 2 Affiliate Hospital, Dalian
No.2 Hospital Affiliated to Jilin University, Changchun
Siping central people's hospital, Siping
Shanghai Putuo District Center Hospital, Shanghai
Nanjing Drum Tower Hosp Affiliated Hosp of Nanjing Univ Med, Nanjing
The Second Affiliated Hospital of Nanjing Medical University, Nanjing
Nanjing First Hospital, Nanjing
The First Affiliated Hospital with Nanjing Medical Universit, Nanjing
Nanjing Jiangning Hospital, Nanjing
Affiliated Hospital of Jiangsu University, Zhenjiang
Changzhou No.2 People's Hospital, Changzhou
Wuxi People's Hospital, Wuxi
The Affliated Jiangyin Hospital of Southeast University Medical College, Jiangyin
Xuzhou central Hospital, Xuzhou
Anhui Provincial Hospital, Hefei
Jinan Central Hospital, Jinan
Tianjin Medical University General Hospital, Tianjin
Chongqing General Hospital, Chongqing
The First People Hospital of Yueyang, Yueyang
Wuhan Central Hospital, Wuhan
Tongji Hosp Tongji Med Col Huazhong Univ of Sci & Tech, Wuhan
The 1st Affiliated Hospital of Henan Science and technology, Luoyang
Guangdong Province People's Hospital, Guangzhou
The First Affiliated Hospital, Sun-Yat Sen University, Guangzhou
Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou
Shantou University Medical College No.2 Affiliated Hospital, Shantou
West China Hospital of Sichuan University, Chengdu
The First Affiliated Hospital of Lanzhou University, Lanzhou
General Hospital of Ningxia Medical University, Yinchuan
1st affiliated Hospital of Shanxi Medical University, Taiyuan
Eli Lilly and Company
INDUSTRY